{"title":"Meet Our Associate Editor","authors":"C. A. Guzmán","doi":"10.2174/157339551302180112103024","DOIUrl":null,"url":null,"abstract":"Dr. Farlow is Professor of Neurology and Vice-Chairman of Research in the Department of Neurology at the Indiana University School of Medicine in Indianapolis. He is also Associate Co-Director of the Indiana Alzheimer’s Disease Center in Indianapolis. Dr. Farlow received his medical degree from Indiana University School of Medicine and completed an internship in medicine and residency in neurology at the Indiana University Hospitals. Dr. Farlow is a member of many professional associations including the American Academy of Neurology, the American Neurological Association, and the American Geriatrics Society. He is also a founding member in both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology. Dr. Farlow has lectured on the topics of aging, dementia, and Alzheimer’s disease at more than 300 meetings, conferences, and hospitals/medical schools throughout the world. He is a reviewer for numerous scientific journals and on the editorial boards of MedLink and Current Alzheimer Research. A prolific author, Dr. Farlow has presented more than 400 abstracts at professional meetings and has authored or co-authored more than 400 articles published in peer-reviewed journals such as Lancet Neurology, the Annals of Family Medicine, and the Journal of the American Geriatrics Society. Dr. Farlow’s research focuses on clinical trials of investigational drugs for the treatment of Alzheimer’s disease and related dementias being the lead investigator for several major studies including; tacrine, donepezil, rivastigmine and interests in trial design and safety. Dr. Farlow also has clinically characterized and helped determine genetic linkage for several familial dementias including the second mutation associated with autosomal dominantly inherited Alzheimer’s disease, GerstmannStraussler-Scheinker disease, and Multi Systems Tauopathy with Dementia.","PeriodicalId":35403,"journal":{"name":"Current Immunology Reviews","volume":"13 1","pages":"99-99"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/157339551302180112103024","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Immunology Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/157339551302180112103024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Dr. Farlow is Professor of Neurology and Vice-Chairman of Research in the Department of Neurology at the Indiana University School of Medicine in Indianapolis. He is also Associate Co-Director of the Indiana Alzheimer’s Disease Center in Indianapolis. Dr. Farlow received his medical degree from Indiana University School of Medicine and completed an internship in medicine and residency in neurology at the Indiana University Hospitals. Dr. Farlow is a member of many professional associations including the American Academy of Neurology, the American Neurological Association, and the American Geriatrics Society. He is also a founding member in both the American Society of Experimental Neurotherapeutics and the International Society for CNS Clinical Trials and Methodology. Dr. Farlow has lectured on the topics of aging, dementia, and Alzheimer’s disease at more than 300 meetings, conferences, and hospitals/medical schools throughout the world. He is a reviewer for numerous scientific journals and on the editorial boards of MedLink and Current Alzheimer Research. A prolific author, Dr. Farlow has presented more than 400 abstracts at professional meetings and has authored or co-authored more than 400 articles published in peer-reviewed journals such as Lancet Neurology, the Annals of Family Medicine, and the Journal of the American Geriatrics Society. Dr. Farlow’s research focuses on clinical trials of investigational drugs for the treatment of Alzheimer’s disease and related dementias being the lead investigator for several major studies including; tacrine, donepezil, rivastigmine and interests in trial design and safety. Dr. Farlow also has clinically characterized and helped determine genetic linkage for several familial dementias including the second mutation associated with autosomal dominantly inherited Alzheimer’s disease, GerstmannStraussler-Scheinker disease, and Multi Systems Tauopathy with Dementia.
期刊介绍:
Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.